3.1. Design
This descriptive cross-sectional study was performed on patients undergoing emergency surgery in hospitals affiliated to the Zanjan University of Medical Sciences (Iran) from March 24 to September 20, 2020.
3.2. Study setting
The research environment in the present study was the hospitals affiliated to the Zanjan University of Medical Sciences in the three cities of Zanjan, Abhar, and Khorramdareh (Ayatollah Mousavi, Al-Ghadir, Emdadi, and Bouali Sina hospitals). In Iran, a patient’s consent is required to perform the surgery. However, getting approval for surgery, besides the patient’s consent, is subject to the signature of a first-degree family member of the patient. Therefore, one of the most important factors influencing a patient’s SDM is the participation of the patient’s family members. Meanwhile, physicians should always provide information about the type of treatment in the presence of family members. Consent is not legal without the signature and consent of a first-degree member of the patient.
3.3 Participant and sampling
The study population consisted of patients who were candidates for emergency surgery referring to the emergency departments of hospitals of the Zanjan University of Medical Sciences. Sampling was done by convenience sampling. Inclusion criteria for patients were having emergency surgery, being alertness, being capacity for informed consent, being age over 18 years, and willingness to participate in the study. Inclusion criteria for the patients’ family members included having age over 18 years, signed the informed consent form for the patient’s surgery, and willingness to participate in the study. We excluded those patients who lost consciousness or the participants who were unwilling to continue participating in the study.
To estimate the sample size, we conducted a pilot study on 30 people. Considering the 95% confidence interval, 80% power of a test, and 0.16 relationship between fear and the level of patients’ participation, we estimated the sample size to be 304. The data from the pilot study included in the main results.
3.4. Measures
Data was collected through three questionnaires. The first questionnaire was about patient profile (i.e., age, sex, education, occupation, marital status, and address). The 9-item Shared Decision-Making Questionnaire (SDM-Q-9) was used to assess participation in obtaining informed consent for surgery. This questionnaire, introduced and validated by Kriston et al., consists of nine items that are scored on a Likert scale, from strongly disagree (0) to strongly agree (5) (18). In this tool, questions 1 to 4 (score range 0–20, score > 10 is non-participation) are related to providing information and ensuring the patient understands the information. Questions 5 and 6 (range 0–10, score less than 5 = non-participation/ score 5 and more than = participation) are related to the level of counseling in treatment decision-making. Finally, Questions 7, 8, and 9 (score range 0–15, score less than 7.5 = non-participation/ score 7.5 and more than = participation) are related to decision-making for treatment. The total score of the questionnaire ranges from 0 to 45. Scores between 0 and 22.5 were non-participation, and scores between 22.6 and 45 were considered participation. The validity and reliability of SDM-Q-9 have been confirmed in a study in Iran on 1,783 oncology patients (19). In the present study, the reliability of the SDM-Q-9 using Cronbach’s alpha method was 0.83.
The factors affecting participation in obtaining informed consent for surgery were prepared based on previous studies (5, 9, 11, 14, 16, 20, 21). These factors included the patient’s triage level, hemodynamic symptoms (heart rate, respiration, and blood pressure), hospitalization experience, length of stay in the emergency room, rush to get informed consent, type of information provided (in writing/orally), pain when getting consent, and the level of fear when getting informed consent. Also, the level of SDM of the patient’s family member (using the SDM-Q-9 questionnaire) and the level of fear of the patient’s family member when getting informed consent were influential factors.
Pain and fear were measured using the Visual Analogue Scale (VAS) (score range 0 to 10). Face validity and content validity were used to evaluate the validity of the questionnaire of factors affecting the patient SDM. The questionnaires were provided to ten experts in medical ethics, and the questionnaire’s face validity and qualitative content validity were confirmed. Inter-rater reliability was used for evaluating the reliability of the questionnaire of factors affecting the patient SDM. Subsequently, two researchers simultaneously and separately evaluated these factors in 20 patients. The kappa agreement coefficient between the two researchers was 97%.
By visiting the emergency department, the researcher identified the eligible participants. If the eligibility criteria were met, the first and third parts of the questionnaire were collected in the emergency department. For patient comfort and reducing the effect of patient clinical condition (as a confounding variable) on completing a questionnaire and increasing data accuracy, SDM-Q-9 was completed by the patient and the patient’s family member after surgery and stabilization of the patient in the surgical ward. To reduce recall bias, we provide the questionnaire to patients and family members as soon as the patient’s condition stabilized.
3.5. Data analysis
SPSS software version 22 was used for data analysis. To check the normality of the data, skewness and kurtosis of the data were examined. The skewness and kurtosis of the data were between − 2 to 2, and the data had a normal distribution. The Exclude Cases Listwise command was used to manage the missing data and remove the outliers. Next, frequency, percentage, mean, and standard deviation were used to evaluate baseline data and patient SDM status. In addition, multiple linear regression was used to predict the patient's SDM variable. Finally, multicollinearity was checked using variance inflation factor (VIF) and tolerable range for all variables included in the model. None of the independent variables was linearly related to each other. The significance level was considered less than.05.
3.6. Ethical considerations
The researcher obtained written consent from the participants (patient and patient’s family members). Participants were assured that all their information would be kept confidential and that they could leave the study at any time if they do not want to.